161 related articles for article (PubMed ID: 34055841)
21. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
[TBL] [Abstract][Full Text] [Related]
22. Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells.
Ou Y; Deng Y; Wang H; Zhang Q; Luo H; Hu P
Front Med (Lausanne); 2021; 8():649279. PubMed ID: 33928106
[No Abstract] [Full Text] [Related]
23. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis.
Liu X; Shen Z
Am J Med Sci; 2020 Dec; 360(6):711-720. PubMed ID: 32988599
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.
Ouyang H; Zhang L; Xie Z; Ma S
Exp Ther Med; 2019 Oct; 18(4):2547-2553. PubMed ID: 31572506
[TBL] [Abstract][Full Text] [Related]
25. LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR.
Liu C; Zhang M; Zhao J; Zhu X; Zhu L; Yan M; Zhang X; Zhang R
Cancer Biother Radiopharm; 2020 May; 35(4):292-300. PubMed ID: 32191537
[No Abstract] [Full Text] [Related]
26. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
[TBL] [Abstract][Full Text] [Related]
27. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression.
Wei Y; Wang Z; Zong Y; Deng D; Chen P; Lu J
Biomed Pharmacother; 2020 May; 125():109890. PubMed ID: 32106369
[TBL] [Abstract][Full Text] [Related]
29. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c.
Xue S; Lu F; Sun C; Zhao J; Zhen H; Li X
World J Surg Oncol; 2021 Apr; 19(1):121. PubMed ID: 33865414
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
33. LncRNA HOXD-AS1 promotes the metastasis of human hepatocellular carcinoma via modulating miR-326/SLC27A4.
Ji W; Wang Q; Yang J
Cancer Cell Int; 2020; 20():161. PubMed ID: 32425696
[TBL] [Abstract][Full Text] [Related]
34. LncRNA ASB16-AS1 Promotes Growth And Invasion Of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis And Activating Wnt/β-Catenin Pathway.
Yao X; You G; Zhou C; Zhang D
Cancer Manag Res; 2019; 11():9371-9378. PubMed ID: 31807066
[TBL] [Abstract][Full Text] [Related]
35. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
[TBL] [Abstract][Full Text] [Related]
36. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
37. DLG1-AS1 is activated by MYC and drives the proliferation and migration of hepatocellular carcinoma cells through miR-497-5p/SSRP1 axis.
Min J; Jin D; Zhang F; Kang Y; Qi Y; Du P
Cancer Cell Int; 2021 Jan; 21(1):16. PubMed ID: 33407499
[TBL] [Abstract][Full Text] [Related]
38. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
[TBL] [Abstract][Full Text] [Related]
39. lncRNA PRR34-AS1 promotes HCC development via modulating Wnt/β-catenin pathway by absorbing miR-296-5p and upregulating E2F2 and SOX12.
Qin M; Meng Y; Luo C; He S; Qin F; Yin Y; Huang J; Zhao H; Hu J; Deng Z; Qiu Y; Hu G; Pan H; Qin Z; Huang Z; Yi T
Mol Ther Nucleic Acids; 2021 Sep; 25():37-52. PubMed ID: 34168917
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA DSCAM-AS1 accelerates the progression of hepatocellular carcinoma via sponging miR-338-3p.
Ji D; Hu G; Zhang X; Yu T; Yang J
Am J Transl Res; 2019; 11(7):4290-4302. PubMed ID: 31396335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
